Somex Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -45.89%
- Profit Growth -32.54%
- Ebitda -46.96%
- Net Worth 10.10%
- Total Assets 7.34%
About Somex Life Sciences
Somex Life Sciences Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 December 2015 (Nine years and one month 25 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Yashvardhan Somani, Rajkumari Somani, and Naresh Somani serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74900RJ2015PTC048910
-
Company No.
048910
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Dec 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Somex Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yashvardhan Somani
|
Director | 01-Aug-2022 | Current |
|
Rajkumari Somani
|
Director | 22-Dec-2015 | Current |
|
Naresh Somani
|
Director | 22-Dec-2015 | Current |
Financial Performance of Somex Life Sciences.
Somex Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 45.89% decrease. The company also saw a substantial fall in profitability, with a 32.54% decrease in profit. The company's net worth Soared by an impressive increase of 10.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Somex Life Sciences?
In 2022, Somex Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Somex Research And Health Private LimitedRajkumari Somani and Naresh Somani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Somex Life Sciences?
Unlock and access historical data on people associated with Somex Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Somex Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Somex Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.